Barber Financial Group, Inc. Axsome Therapeutics, Inc. Transaction History

Barber Financial Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$55.91 - $81.44 $139,775 - $203,600	-2,500 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$66.31 - $86.52 $165,775 - $216,300	2,500 New	2,500 $204,000
Q3 2020 Nov 04, 2020	SELL	$68.34 - $85.84 $170,850 - $214,600	-2,500 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$49.87 - $98.69 $124,675 - $246,725	2,500 New	2,500 $206,000
Q1 2020 May 08, 2020	SELL	$41.2 - $101.31 $103,000 - $253,275	-2,500 Closed	0 $0

Q4 2019 Feb 21, 2020	BUY	$16.71 - $106.24 $41,775 - $265,600	2,500 New	2,500 $258,000

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.52B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Barber Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Barber Financial Group, Inc. with notifications on news.